Evidence map›Paper›PMID 38370097›Full record

ArticleThe Pan African medical journal2023

Innovative strategies developed to mitigate the impact of COVID-19 pandemic on polio surveillance in Nigeria, 2020.

Aboyowa Arayuwa Edukugho, Sume Gerald Etapelong, Saheed Gidado, Samuel Luka Abbott, Abdullahi Walla Hamisu, Isiaka Ayodeji Hassan, Kabir Yusuf Mawashi, Tesfaye Bedada Erbeto, Ndadilnasiya Endie Waziri, Patrick Nguku and 2 more

Abstract read
In one paragraph

Article in The Pan African medical journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Aboyowa Arayuwa EdukughoAfrican Field Epidemiology Network, Federal Capital Territory (FCT), Abuja, Nigeria.
Sume Gerald EtapelongWorld Health Organization, Country Office, Abuja, Nigeria.
Saheed GidadoAfrican Field Epidemiology Network, Federal Capital Territory (FCT), Abuja, Nigeria.
Samuel Luka AbbottAfrican Field Epidemiology Network, Federal Capital Territory (FCT), Abuja, Nigeria.
Abdullahi Walla HamisuWorld Health Organization, Country Office, Abuja, Nigeria.
Isiaka Ayodeji HassanWorld Health Organization, Country Office, Abuja, Nigeria.
Kabir Yusuf MawashiNational Primary Healthcare Development Authority, Federal Capital Territory (FCT), Abuja, Nigeria.
Tesfaye Bedada ErbetoWorld Health Organization, Country Office, Abuja, Nigeria.
Ndadilnasiya Endie WaziriAfrican Field Epidemiology Network, Federal Capital Territory (FCT), Abuja, Nigeria.
Patrick NgukuAfrican Field Epidemiology Network, Federal Capital Territory (FCT), Abuja, Nigeria.
Bolu OmotayoCenters for Disease Control and Prevention, Atlanta, Georgia, United States.
Usman Said AdamuNational Primary Healthcare Development Authority, Federal Capital Territory (FCT), Abuja, Nigeria.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Introduction: following the spread of the COVID-19 pandemic to Nigeria, the Federal Government of Nigeria restricted human and vehicular movements to curb the spread of the disease. This action had a negative impact on Acute Flaccid Paralysis (AFP) surveillance, with a resultant reduction in the number of AFP cases reported. This paper describes the impact of the COVID-19 pandemic on poliovirus surveillance in Nigeria and the proactive interventions by Nigeria´s polio program to mitigate the impact of COVID-19 on polio surveillance. Methods: nine innovative strategies were implemented in all 774 Local Government Areas (LGA) of the 36 states and Federal Capital Territory (FCT) of the country. These strategies were developed by the national surveillance officers and operationalized by sub-national surveillance officers with different strategies starting at different epidemiological weeks from week 14 to 23, 2020. Many of the strategy innovations were technology-based and included: the use of mobile phones to send the AFP case definition and video by WhatsApp or by SMS, the use of state-specific toll-free numbers and Mobile Telephone Network (MTN) (mobile service provider) CallerfeelTM to community informants (CI) who were the main targets of the interventions to increase case detection and reporting. Others included the use of abridged e-surveillance integrated supportive supervision (ISS) checklists, virtual monthly DSNO meetings, and batched AFP stool specimen transportation network. Results: compared to the same period in 2019, the cumulative rate of AFP case detection and reporting had gradually declined from 39.1% in January to 16.7% before the commencement of the interventions in week 20, 2020. However, the detection and reporting increased by 57.% from week 20 to week 47 compared to the same period in 2019. This is because with COVID-19, hospital visitation dropped, and the sick remained in the communities, so the CI network was relied on to detect and report AFP cases. The cumulative proportion of AFP cases reported by community informants as of week 47 increased from 13% in 2018 to 21% in 2020. This indicates an increase of 38%. Thirty-five AFP cases were detected and reported using the MTN Caller Feel strategy, while 15 cases were reported through state-specific toll-free numbers. Conclusion: the implementation of the innovative strategies was able to mitigate the low AFP case detection and reporting observed at the initial stage of the COVID-19 pandemic. The use of technology facilitated reaching the CI network, which was more instrumental in detecting and reporting the cases.

Indexed as

COVID-19PoliomyelitisPoliovirusHumansNigeriaPandemicsParalysisPopulation SurveillanceAcute Flaccid Paralysis surveillanceCOVID-19 pandemicinnovativepolio eradicationstrategiessurveillance officers

Identifiers

PMID38370097
PMCPMC10874093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.